Clonidine to Prevent Postictal Delirium After ElectroConvulsive Therapy: a Triple-blind, Single-centre study.
This study is completed in Switzerland. It focuses on depression; Catatonia; Bipolarity; Delirium Postseizure.
Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
Your next step
The official record suggests in-person participation through a hospital, with sites including Department of Anaesthesiology and Pain Medicine, Bern University Hospital, University of Bern. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually being able to understand the study and consent and meeting the main study requirements, while common reasons not to take part include active substance or alcohol problems that could affect the results. This is a later-stage study, which usually means the approach is being followed in broader real-world use.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Recruitment status
- Completed
- Estimated enrollment
- Not clearly listed
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Behavioral / psychological / psychosocial
- Study phase
- Not clearly listed
- Locations
- Switzerland
- Age range
- Over 18 Years
- Official registry ID
- NCT04828226
- Official title
- Clonidine to Prevent Postictal Delirium After ElectroConvulsive Therapy: a Randomised, Placebo-controlled, Triple-blind, Single-centre Trial.
- Official source
- Official registry link
Want help reviewing this study?
For you
Taking part may help test a support approach in real life.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in Switzerland.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring psychotherapy or therapy for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with placebo. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study. Phase is mainly useful to check for medication studies and some device studies.
Do I need to want to stop or reduce tobacco use to participate?
The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Could this study affect my mood, habits, motivation, or stress?
Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Insel Gruppe AG, University Hospital Bern, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that this study is completed. It may still be useful for understanding the research, but you are unlikely to be able to join.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me
